The bill introduced by Senator Craig aims to enact a new section, 3902.65, in the Revised Code of Ohio, which establishes a cap on cost sharing for prescription insulin drugs. Specifically, it defines "prescription insulin drug" as any prescription medication containing insulin used for diabetes treatment. The bill mandates that health plan issuers cannot require cost sharing for these covered insulin drugs to exceed thirty-five dollars for a thirty-day supply, regardless of the type or amount of insulin prescribed.

This legislation is designed to alleviate the financial burden on individuals requiring insulin by ensuring that their out-of-pocket costs remain manageable. The cap on cost sharing applies to health benefit plans that are amended, issued, or renewed after the effective date of this section, thereby providing immediate relief to those affected by high insulin prices.